Salt Lake City-based Predictive Technology Group Inc. has acquired Inception Dx, a diagnostic laboratory, also based in Salt Lake City. The acquisition of Inception Dx includes next-generation sequencing and genotyping assets along with extensive protocols, quality and laboratory management systems and other resources required by a “high complexity” molecular diagnostic laboratory, according to a release from Predictive.
Predictive is a provider of data analytics for disease identification and subsequent therapeutic intervention through biotechnology treatments. It said Inception Dx will operate as a wholly owned subsidiary of Predictive Technology Group. “We are excited to offer next-generation sequencing and genotyping that will allow Predictive Technology Group to further leverage and accelerate the commercialization of diagnostics and therapeutics from our unique development platforms,” said Bradley Robinson, CEO of Predictive.
Predictive Diagnostics also said it will launch ARTGuide, a proprietary gene test panel for women experiencing infertility as a result of endometriosis and other health concerns, during the fourth quarter of 2018. The company said the test is expected to change the way that advanced reproductive technologies, such as in vitro fertilization, are used to assist couples having difficulty conceiving.